Replies to post #1676 on Theralink Technologies Inc (THER)

[learningcurve2020]

Thank you for that commentary, CEO Head.

[BooDog]

P2 trial for ProscaVax at Beth Israel Deaconess Medical Center of Harvard Medical School puts OncBiomune on the map imo. Though I will submit that it will be watched more for the results. But on the map imo. The drugs and the potential expanding of the product lines both in the U.S. and Europe is excellent and having a revenue stear in Mexico is great.

I do think we should see kick off news soon for the ProscaVax trial at Beth. This isn't a small thing for them either, Beth IS ONE OF THE BEST.
http://oncbiomune.com/2017/06/01/protocol-submitted-to-fda-for-phase-2-clinical-trial-of-proscavax-as-immunotherapy-for-early-stage-prostate-cancer/


BTW, Just picked up a chunk at .075.

Next week the market should resemble some form of summertime normalcy since so many took this whole week off.

Be green!!

[Maple tree]

Clinical trials proposed for phase2/3 with over 100 patients are not cheap, and something about 20 to 40 millions, I guess. plus expenses for Mexican trials. We are probably talking about about 50 millions. Not sure to sell drugs in Mexico will be profitable. Considering all these sencenarios, I would wait and see what will happen or wait for phase1 data.